Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic

P. Jansa, R. Becvar, D. Ambroz, T. Palecek, M. Tomcik, S. Skacelova, M. Aschermann, A. Linhart,

. 2012 ; 31 (3) : 557-61.

Language English Country Germany

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK ProQuest Central from 1997-01-01 to 2017-12-31
Medline Complete (EBSCOhost) from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest) from 1997-01-01 to 2017-12-31

BACKGROUND: Systemic sclerosis (SSc) is an important cause of pulmonary arterial hypertension (PAH), with an estimated prevalence of 7.85-26.7%. OBJECTIVE: Our aim was to estimate the prevalence of PAH among patients with SSc in the Czech Republic and to compare haemodynamics in SSc patients diagnosed with PAH through screening with those diagnosed previously, based on symptoms. METHODS: During 2007, SSc patients in the Czech Republic, without significant pulmonary function impairment or cardiac disease, underwent screening for PAH with transthoracic echocardiography. Those with a tricuspid regurgitant (TR) jet gradient suggestive of PAH (>30 mmHg) underwent subsequent right heart catheterisation (RHC) to confirm the diagnosis (mean pulmonary arterial pressure, mPAP, ≥25 mmHg; pulmonary capillary wedge pressure, ≤15 mmHg). Haemodynamics in patients diagnosed with PAH in this way were compared with those in patients diagnosed previously, based on symptoms. RESULTS: Two hundred and three SSc patients (mean age, 53.8 ± 13 years; 82.3% women) from 26 rheumatology practices were screened. Among these, 17 had a TR jet gradient >30 mmHg and underwent RHC; PAH was confirmed in six patients. These six patients were found to have significantly lower mPAP than nine patients diagnosed previously with PAH, based on symptoms (31.17 ± 5.56 vs. 46.89 ± 9.48 mmHg, p = 0.0014). CONCLUSION: Prevalence of PAH in our SSc cohort was 7.08%. SSc patients diagnosed with PAH through screening have less advanced disease in terms of haemodynamics than those with PAH diagnosed previously based on symptoms; their prognosis is therefore likely to be more favourable.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12034853
003      
CZ-PrNML
005      
20121206125331.0
007      
ta
008      
121023s2012 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10067-011-1896-x $2 doi
035    __
$a (PubMed)22105781
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Jansa, Pavel $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, Charles University, U nemocnice 2, Prague 2 12808, Czech Republic. jansapavel@yahoo.com
245    10
$a Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic / $c P. Jansa, R. Becvar, D. Ambroz, T. Palecek, M. Tomcik, S. Skacelova, M. Aschermann, A. Linhart,
520    9_
$a BACKGROUND: Systemic sclerosis (SSc) is an important cause of pulmonary arterial hypertension (PAH), with an estimated prevalence of 7.85-26.7%. OBJECTIVE: Our aim was to estimate the prevalence of PAH among patients with SSc in the Czech Republic and to compare haemodynamics in SSc patients diagnosed with PAH through screening with those diagnosed previously, based on symptoms. METHODS: During 2007, SSc patients in the Czech Republic, without significant pulmonary function impairment or cardiac disease, underwent screening for PAH with transthoracic echocardiography. Those with a tricuspid regurgitant (TR) jet gradient suggestive of PAH (>30 mmHg) underwent subsequent right heart catheterisation (RHC) to confirm the diagnosis (mean pulmonary arterial pressure, mPAP, ≥25 mmHg; pulmonary capillary wedge pressure, ≤15 mmHg). Haemodynamics in patients diagnosed with PAH in this way were compared with those in patients diagnosed previously, based on symptoms. RESULTS: Two hundred and three SSc patients (mean age, 53.8 ± 13 years; 82.3% women) from 26 rheumatology practices were screened. Among these, 17 had a TR jet gradient >30 mmHg and underwent RHC; PAH was confirmed in six patients. These six patients were found to have significantly lower mPAP than nine patients diagnosed previously with PAH, based on symptoms (31.17 ± 5.56 vs. 46.89 ± 9.48 mmHg, p = 0.0014). CONCLUSION: Prevalence of PAH in our SSc cohort was 7.08%. SSc patients diagnosed with PAH through screening have less advanced disease in terms of haemodynamics than those with PAH diagnosed previously based on symptoms; their prognosis is therefore likely to be more favourable.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a kohortové studie $7 D015331
650    _2
$a komorbidita $7 D015897
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a plicní hypertenze $x komplikace $x diagnóza $x epidemiologie $x patofyziologie $7 D006976
650    _2
$a plíce $x patofyziologie $7 D008168
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prevalence $7 D015995
650    _2
$a arteria pulmonalis $x patofyziologie $7 D011651
650    _2
$a respirační funkční testy $7 D012129
650    _2
$a systémová sklerodermie $x komplikace $x epidemiologie $x patofyziologie $7 D012595
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Becvar, Radim
700    1_
$a Ambroz, David $7 gn_A_00005391
700    1_
$a Palecek, Tomas
700    1_
$a Tomcik, Michal
700    1_
$a Skacelova, Simona
700    1_
$a Aschermann, Michael $7 nlk19990072993
700    1_
$a Linhart, Ales
773    0_
$w MED00001162 $t Clinical rheumatology $x 1434-9949 $g Roč. 31, č. 3 (2012), s. 557-61
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22105781 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a
990    __
$a 20121023 $b ABA008
991    __
$a 20121206125404 $b ABA008
999    __
$a ok $b bmc $g 956863 $s 792350
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 31 $c 3 $d 557-61 $i 1434-9949 $m Clinical rheumatology $n Clin Rheumatol $x MED00001162
LZP    __
$a Pubmed-20121023

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...